CD4+ and CD8+ T cell therapy targeting CMV and adenovirus
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD4+ and CD8+ T cell therapy targeting CMV and adenovirus, covering 2025-09-05 to 2025-09-05. Get the full timeline:
Most recent: Clinical Trial Update: Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus [Phase 1, Phase 2]